Watermark
  Back to Search Results

BGB-A317-209

Recruiting

Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-209

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03736889

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20180867

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents